FluoroPharma Medical of Montclair, New Jersey, is committed to the discovery, development, and commercialization novel molecular positron emission tomography (PET) agents for the cardiovascular, oncology and neurology arenas. The Company’s broad technology platform was developed in conjunction with leading scientists from Massachusetts General Hospital and Harvard Medical School.
Our initial focus is the development of breakthrough PET imaging agents for the detection and assessment of acute and chronic forms of coronary artery disease (CAD). Other products in development include agents for detection of inflamed atherosclerotic plaque in peripheral arteries.
Company Details
- Employees
- 2
- Founded
- -
- Address
- 8 Hillside Ave, Montclair,nj 07042,united States
- Phone
- 119737441565
- in****@****rma.com
- Industry
- Biotechnology
- Website
- fluoropharma.com
- Keywords
- Fluorine chemistry, positron emission tomography, cardiovascular disease, and discovery, development and commercialization.
- HQ
- Montclair, NJ
Fluoropharma Medical Inc. Questions
Fluoropharma Medical Inc.'s helpline number is 119737441565
Fluoropharma Medical Inc.'s website is fluoropharma.com
Fluoropharma Medical Inc.'s LinkedIn profile is https://www.linkedin.com/company/fluoropharma
Fluoropharma Medical Inc. has
2 employees.
View email and phone details for 2
employees at Fluoropharma Medical Inc..
Fluoropharma Medical Inc.'s industry is
Biotechnology
Fluoropharma Medical Inc.'s top competitors are
Kbp Biosciences,
Alf Sahel Sa,
Falcon Energy Materials Plc,
Alf Sahel S.a.,
Charcuterie Sahel,
Navidea Biopharmaceuticals,
Lantheus,
Entero Therapeutics (Nasdaq: Ento),
Perspective Therapeutics,
Viewpoint Molecular Targeting, Inc..
Fluoropharma Medical Inc.'s support email address is info@fluoropharma.com
Fluoropharma Medical Inc.'s categories are Biotechnology
Fluoropharma Medical Inc.'s founding year is 2003
